Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies
PHASE3
The purpose of this open-label, single arm, multicenter extension study is ...
Study of Efficacy and Safety of Inclisiran in Asian Participants With Atherosclerotic Cardiovascular Disease (ASCVD) or ASCVD High Risk and Elevated Low Density Lipoprotein Cholesterol (LDL-C)
PHASE3
A multicenter study to evaluate safety and efficacy of inclisiran in Asian ...
A Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in ASCVD Patients With Hypercholesterolemia, ASCVD-risk Equivalent Patients With Hypercholesterolemia and Familial Hypercholesterolemia
N/A
This was a descriptive, non-interventional, retrospective cohort study amon...
Status
Completed
Location
Novartis
Start Date
2022-10-03
Trial ID
NCT06507852
German Inclisiran Network: Retrospective Registry of Patients Being Treated With the siRNA Inclisiran in Germany
N/A
The German Inclisiran Network is a registry of patients with hypercholester...
Status
Unknown
Location
Jena University Hospital
Start Date
2020-12-11
Trial ID
NCT05438069
VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)
NA
The goal of this study is to understand and compare an alternative model of...
Status
Terminated
Location
Manningham General Practice, 200 High St, Templestowe Lower
Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing Polysorbate 80 Compared to the Currently Marketed Formulation
PHASE1
The purpose of this study is to compare safety, tolerability, pharmacokinet...